Journal
/
Krebsforschung
/
Fields Tedavisi Tümör kullanma Kanserli Hücreleri için optimum inhibitör Frekans (TTFields) Belirlenmesi
JoVE Journal
Krebsforschung
This content is Free Access.
JoVE Journal Krebsforschung
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
Please note that all translations are automatically generated. Click here for the English version.

Fields Tedavisi Tümör kullanma Kanserli Hücreleri için optimum inhibitör Frekans (TTFields) Belirlenmesi

14,247 Views

•

08:14 min

•

May 04, 2017

DOI:

10.3791/55820-v

DOI:
10.3791/55820-v

•

08:14 min
May 04, 2017

•

3 Views
, , , , , , , , , , , ,
1Preclinical Research Department,Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland

Tags

Tumor Treating Fields (TTFields)In VitroCancer CellsInhibitory FrequencyCell Growth InhibitionU-87 MG CellsDMEM MediumCell SuspensionCoverslipGrowth MediumRefrigerated IncubatorElectric Field IntensityTTFields GeneratorPre-clinical IdentificationCombined TreatmentChemotherapyRadiation Therapy

Read Article

Cite this Article

Porat, Y., Giladi, M., Schneiderman, R. S., Blat, R., Shteingauz, A., Zeevi, E., Munster, M., Voloshin, T., Kaynan, N., Tal, O., Kirson, E. D., Weinberg, U., Palti, Y. Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields). J. Vis. Exp. (123), e55820, doi:10.3791/55820 (2017).

Download .ris file

Copy

Share Video

.

Copy